パニック発作治療の世界市場レポート 2025年

パニック発作治療の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR17.6％で68億6,000万米ドルに成長します。予測期間における成長の原動力は、あらゆる年齢層における不安障害やパニック障害の有病率の上昇、遠隔医療やデジタル治療アプリの採用拡大、個別化・精密精神医学への注目の高まり、メンタルヘルス関連の新興企業やイノベーションへの投資の増加、メンタルヘルスサービス提供における官民連携の強化などです。予測期間における主な動向には、仮想現実ベースの暴露療法の主流採用、認知行動療法を提供するためのモバイルアプリの増加、ホリスティックで統合的な治療アプローチへのシフト、不安のリアルタイム追跡のためのウェアラブルバイオセンサーの使用の増加、臨床レジメンへのマインドフルネスと瞑想の組み込みなどが含まれます。

不安の有病率の上昇は、パニック発作治療市場の成長を促進すると予想されます。不安は、心配、緊張、恐怖の持続的な感情によって特徴づけられる精神的健康状態であり、しばしば落ち着きのなさ、心拍の速さ、集中困難などの身体的症状を伴う。現代生活のプレッシャーは、高い生産性、経済的安定、社会的成功を要求し、休息や感情的回復の余地をほとんど与えないことによって、不安レベルを高める一因となっています。パニック発作治療は、一人ひとりに合わせたタイムリーな介入により、症状を緩和し、感情的な幸福を改善し、生活のコントロールを取り戻すための効果的な解決策を提供することで、不安に対処するものです。例えば、2024年5月、米国精神医学会（APA）は、米国の成人の数が増加しており、2023年には37％、2022年には32％であったのに対し、2024年には43％の成人がより高い不安レベルを経験していると報告しています。その結果、不安の有病率の増加がパニック発作治療に対する需要を牽引しています。

パニック発作治療市場の主要企業は、デジタル不安解消プラットフォームなどの医療技術の進歩に注目し、利用しやすい技術主導型のソリューションで不安やパニック発作の管理を改善しようとしています。これらのプラットフォームは、誘導瞑想、認知行動療法（CBT）モジュール、ムードトラッキング、リラクゼーションエクササイズなどのツールを使用して、個人が不安を管理・軽減できるように設計された技術ベースのアプリケーションまたはサービスです。例えば、米国を拠点とするメンタルヘルス新興企業CalmiGo社は、2024年10月、不安やパニック発作をより効果的に管理するための高度なデジタル・プラットフォームCalmiGo Plusを発表しました。このプラットフォームには、特許を取得したセンサーベースの呼気装置と、ゲーミフィケーションとパーソナライズされた治療技術を活用してメンタルヘルスの成果を改善するコンパニオンモバイルアプリが含まれます。この技術革新は、ユーザーに薬物を使用しない即時的な救済を提供すると同時に、経時的な経過を追跡し、利用しやすくデータ主導型の不安治療ソリューションの大きな飛躍を示すものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のパニック発作治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のパニック発作治療市場：成長率分析
• 世界のパニック発作治療市場の実績：規模と成長, 2019-2024
• 世界のパニック発作治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界のパニック発作治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のパニック発作治療市場：治療タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 認知行動療法（CBT）
• 医薬品
• その他の治療の種類
• 世界のパニック発作治療市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗うつ薬
• 抗不安薬
• カルシトニン遺伝子関連ペプチド（CGRP）拮抗薬
• その他の薬物クラス
• 世界のパニック発作治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 静脈内
• 筋肉内
• 舌下
• その他の投与経路
• 世界のパニック発作治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のパニック発作治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• メンタルヘルスケアセンター
• その他の用途
• 世界のパニック発作治療市場、認知行動療法（CBT）、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 曝露療法
• 弁証法的行動療法（DBT）
• 受容とコミットメント療法（ACT）
• マインドフルネスに基づく認知療法（MBCT）
• 理性情動行動療法（REBT）
• 世界のパニック発作治療市場、医薬品、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ベータ遮断薬
• ブスピロン
• 抗けいれん薬
• 非定型抗精神病薬
• ハーブと天然サプリメント
• 世界のパニック発作治療市場、その他の治療タイプ、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• テレサイキアトリー
• バイオフィードバックとニューロフィードバック
• バーチャルリアリティセラピー
• モバイルヘルスアプリケーション
• サポートグループとカウンセリングサービス

第7章 地域別・国別分析

• 世界のパニック発作治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のパニック発作治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• パニック発作治療市場：競合情勢
• パニック発作治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca Plc
• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Sumitomo Dainippon Pharma
• Shionogi & Co. Ltd.
• Lundbeck A/S
• Recordati Rare Diseases
• Torrent Pharmaceuticals Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• パニック発作治療市場2029：新たな機会を提供する国
• パニック発作治療市場2029：新たな機会を提供するセグメント
• パニック発作治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Panic attack treatment refers to a range of medical and psychological interventions designed to manage, reduce, and prevent sudden, intense episodes of fear or discomfort, marked by physical and emotional distress. These treatments aim to restore emotional stability, minimize disruptions to daily functioning, and support long-term mental well-being for individuals affected by panic-related disorders.

The main treatment types for panic attacks include cognitive behavioral therapy (CBT), medications, and others. Cognitive behavioral therapy (CBT) is a structured, time-limited psychotherapeutic approach used in treating panic attacks, helping individuals identify and alter negative thought patterns and behaviors that trigger or exacerbate anxiety symptoms. The drug classes used in these treatments include antidepressants, anti-anxiety medications, calcitonin gene-related peptide (CGRP) antagonists, and others. These medications are administered through various routes such as oral, intravenous, intramuscular, sublingual, and more, and are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies. They are used in settings such as hospitals, mental healthcare centers, and others.

The panic attack treatment market research report is one of a series of new reports from The Business Research Company that provides panic attack treatment market statistics, including panic attack treatment industry global market size, regional shares, competitors with a panic attack treatment market share, detailed panic attack treatment market segments, market trends and opportunities, and any further data you may need to thrive in the panic attack treatment industry. This panic attack treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The panic attack treatment market size has grown rapidly in recent years. It will grow from $3.04 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth during the historic period can be attributed to a reduction in public stigma surrounding mental health conditions, an increase in awareness campaigns by health organizations, rising diagnosis rates of anxiety disorders in developed regions, the inclusion of mental health in primary healthcare settings, and the expansion of private mental health clinics.

The panic attack treatment market size is expected to see rapid growth in the next few years. It will grow to $6.86 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period is driven by the rising prevalence of anxiety and panic disorders across all age groups, greater adoption of telehealth and digital therapy apps, a stronger focus on personalized and precision psychiatry, increased investments in mental health startups and innovations, and enhanced public-private partnerships in mental health service delivery. Key trends in the forecast period include the mainstream adoption of virtual reality-based exposure therapy, a rise in mobile apps for delivering cognitive behavioral therapy, a shift toward holistic and integrative treatment approaches, growing use of wearable biosensors for real-time anxiety tracking, and the incorporation of mindfulness and meditation into clinical regimens.

The rising prevalence of anxiety is expected to drive the growth of the panic attack treatment market. Anxiety is a mental health condition marked by persistent feelings of worry, nervousness, and fear, often accompanied by physical symptoms such as restlessness, rapid heartbeat, and difficulty concentrating. The pressures of modern life contribute to increasing anxiety levels by demanding high productivity, financial stability, and social success, leaving little room for rest or emotional recovery. Panic attack treatments address anxiety by providing effective solutions to alleviate symptoms, improve emotional well-being, and help individuals regain control of their lives through personalized and timely interventions. For example, in May 2024, the American Psychiatric Association (APA) reported that a growing number of U.S. adults are feeling more anxious, with 43% of adults in 2024 experiencing higher anxiety levels compared to 37% in 2023 and 32% in 2022. As a result, the increasing prevalence of anxiety is driving the demand for panic attack treatments.

Leading companies in the panic attack treatment market are focusing on advancements in medical technology, such as digital anxiety relief platforms, to improve the management of anxiety and panic attacks with accessible, technology-driven solutions. These platforms are technology-based applications or services designed to help individuals manage and reduce anxiety using tools such as guided meditation, cognitive behavioral therapy (CBT) modules, mood tracking, and relaxation exercises. For instance, in October 2024, CalmiGo, a U.S.-based mental health startup, launched CalmiGo Plus, an advanced digital platform aimed at supporting users in managing anxiety and panic attacks more effectively. The platform includes a patented, sensor-based exhaler device and a companion mobile app that leverages gamification and personalized therapeutic techniques to improve mental health outcomes. This innovation offers users immediate, drug-free relief while also tracking their progress over time, marking a significant leap forward in accessible and data-driven anxiety treatment solutions.

In August 2024, AbbVie Inc., a U.S.-based biopharmaceutical company, acquired Cerevel Therapeutics for \$8.7 billion. With this acquisition, AbbVie aimed to strengthen its neuroscience portfolio by gaining access to Cerevel's promising pipeline of treatments for psychiatric and neurological disorders, including anxiety and panic-related conditions. Cerevel Therapeutics, a U.S.-based clinical-stage biopharmaceutical company, focuses on developing therapies for neuroscience-related diseases, including panic attacks.

Major players in the panic attack treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Shionogi & Co. Ltd., Lundbeck A/S, Recordati Rare Diseases, and Torrent Pharmaceuticals Ltd.

North America was the largest region in the panic attack treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in panic attack treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the panic attack treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The panic attack treatment market consists of revenues earned by entities by providing services such as exposure therapy sessions, dialectical behavior therapy, telepsychiatry and remote consultation services, mental wellness subscription platforms, supportive counseling and peer group therapy, and personalized mental health coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The panic attack treatment market also includes sales of biofeedback and neurofeedback devices, virtual reality-based therapy solutions, mobile mental health applications, genetic testing kits for psychiatric profiling, mental health diagnostic and screening tools, wearable devices for anxiety monitoring, AI-powered therapeutic chatbots, and digital therapeutic platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panic Attack Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on panic attack treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for panic attack treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panic attack treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Cognitive Behavioral Therapy (CBT); Medications; Other Treatment Types
• 2) By Drug Class: Antidepressants; Anti-Anxiety Drugs; Calcitonin Gene-Related Peptide (CGRP) Antagonists; Other Drug Classes
• 3) By Route Of Administration: Oral; Intravenous; Intramuscular; Sublingual; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By Application: Hospitals; Mental Healthcare Centers; Other Applications
• Subsegments:
• 1) By Cognitive Behavioral Therapy (CBT): Exposure Therapy; Dialectical Behavior Therapy (DBT); Acceptance And Commitment Therapy (ACT); Mindfulness-Based Cognitive Therapy (MBCT); Rational Emotive Behavior Therapy (REBT)
• 2) By Medications: Beta Blockers; Buspirone; Anticonvulsants; Atypical Antipsychotics; Herbal And Natural Supplements
• 3) By Other Treatment Types: Telepsychiatry; Biofeedback And Neurofeedback; Virtual Reality Therapy; Mobile Health Applications; Support Groups And Counseling Services
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Panic Attack Treatment Market Characteristics

3. Panic Attack Treatment Market Trends And Strategies

4. Panic Attack Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Panic Attack Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Panic Attack Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Panic Attack Treatment Market Growth Rate Analysis
• 5.4. Global Panic Attack Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Panic Attack Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Panic Attack Treatment Total Addressable Market (TAM)

6. Panic Attack Treatment Market Segmentation

• 6.1. Global Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Behavioral Therapy (CBT)
• Medications
• Other Treatment Types
• 6.2. Global Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antidepressants
• Anti-Anxiety Drugs
• Calcitonin Gene-Related Peptide (CGRP) Antagonists
• Other Drug Classes
• 6.3. Global Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Intramuscular
• Sublingual
• Other Routes Of Administration
• 6.4. Global Panic Attack Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Panic Attack Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Mental Healthcare Centers
• Other Applications
• 6.6. Global Panic Attack Treatment Market, Sub-Segmentation Of Cognitive Behavioral Therapy (CBT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exposure Therapy
• Dialectical Behavior Therapy (DBT)
• Acceptance And Commitment Therapy (ACT)
• Mindfulness-Based Cognitive Therapy (MBCT)
• Rational Emotive Behavior Therapy (REBT)
• 6.7. Global Panic Attack Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Beta Blockers
• Buspirone
• Anticonvulsants
• Atypical Antipsychotics
• Herbal And Natural Supplements
• 6.8. Global Panic Attack Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Telepsychiatry
• Biofeedback And Neurofeedback
• Virtual Reality Therapy
• Mobile Health Applications
• Support Groups And Counseling Services

7. Panic Attack Treatment Market Regional And Country Analysis

• 7.1. Global Panic Attack Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Panic Attack Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Panic Attack Treatment Market

• 8.1. Asia-Pacific Panic Attack Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Panic Attack Treatment Market

• 9.1. China Panic Attack Treatment Market Overview
• 9.2. China Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Panic Attack Treatment Market

• 10.1. India Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Panic Attack Treatment Market

• 11.1. Japan Panic Attack Treatment Market Overview
• 11.2. Japan Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Panic Attack Treatment Market

• 12.1. Australia Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Panic Attack Treatment Market

• 13.1. Indonesia Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Panic Attack Treatment Market

• 14.1. South Korea Panic Attack Treatment Market Overview
• 14.2. South Korea Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Panic Attack Treatment Market

• 15.1. Western Europe Panic Attack Treatment Market Overview
• 15.2. Western Europe Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Panic Attack Treatment Market

• 16.1. UK Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Panic Attack Treatment Market

• 17.1. Germany Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Panic Attack Treatment Market

• 18.1. France Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Panic Attack Treatment Market

• 19.1. Italy Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Panic Attack Treatment Market

• 20.1. Spain Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Panic Attack Treatment Market

• 21.1. Eastern Europe Panic Attack Treatment Market Overview
• 21.2. Eastern Europe Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Panic Attack Treatment Market

• 22.1. Russia Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Panic Attack Treatment Market

• 23.1. North America Panic Attack Treatment Market Overview
• 23.2. North America Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Panic Attack Treatment Market

• 24.1. USA Panic Attack Treatment Market Overview
• 24.2. USA Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Panic Attack Treatment Market

• 25.1. Canada Panic Attack Treatment Market Overview
• 25.2. Canada Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Panic Attack Treatment Market

• 26.1. South America Panic Attack Treatment Market Overview
• 26.2. South America Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Panic Attack Treatment Market

• 27.1. Brazil Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Panic Attack Treatment Market

• 28.1. Middle East Panic Attack Treatment Market Overview
• 28.2. Middle East Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Panic Attack Treatment Market

• 29.1. Africa Panic Attack Treatment Market Overview
• 29.2. Africa Panic Attack Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Panic Attack Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Panic Attack Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Panic Attack Treatment Market Competitive Landscape And Company Profiles

• 30.1. Panic Attack Treatment Market Competitive Landscape
• 30.2. Panic Attack Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Panic Attack Treatment Market Other Major And Innovative Companies

• 31.1. AstraZeneca Plc
• 31.2. Abbott Laboratories
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline plc
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Eli Lilly and Company
• 31.7. Viatris Inc.
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Bausch Health Companies Inc.
• 31.10. Sun Pharmaceutical Industries Ltd.
• 31.11. Sumitomo Dainippon Pharma
• 31.12. Shionogi & Co. Ltd.
• 31.13. Lundbeck A/S
• 31.14. Recordati Rare Diseases
• 31.15. Torrent Pharmaceuticals Ltd.

32. Global Panic Attack Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Panic Attack Treatment Market

34. Recent Developments In The Panic Attack Treatment Market

35. Panic Attack Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Panic Attack Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Panic Attack Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Panic Attack Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer